Search By Initial

Name Index S

• Siponimod (Catalog# : 185111, Cas# : 1230487-85-0)Siponimod, also known as BAF-312, is a a potent and orally selective S1P Receptor Modulator with EC50 value of 0.39nM for S1P1 receptors and 0.98nM for S1P5 receptors, respective
• SEL120-34A HCl (Catalog# : 18574, Cas# : 1609452-30-3)SEL120-34A is a potent and selective CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains.
• SR-4370 (Catalog# : 1842814, Cas# : 1816294-67-3)SR-​4370 is an HDAC inhibitor.
• SGC2085 HCl (Catalog# : 184287, Cas# : 1821908-49-9)SGC2085 is a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor with an IC50 of 50 nM and more than undred-fold selectivity over other PRM
• S38093 HCl (Catalog# : 184176, Cas# : 1222097-72-4)S38093 is an inverse agonist at histamine H3 receptors.
• STO-609 acetate (Catalog# : 184123, Cas# : 1173022-21-3)STO-609 is a cell-permeable inhibitor of calcium/calmodulin-dependent kinase kinases (CaMKK) isoforms CaMKKα and CaMKKβ (Ki = 80 and 15 ng/ml, respectively).
• Super-TDU (Catalog# : 18495, Cas# : 1599441-71-0)Super-TDU is an inhibitory polypeptide targeting yap-teads interaction.
• SSD114 HCl (Catalog# : 18427, Cas# : N/A)SSD114 is a GABAB positive allosteric modulator. SSD114 potentiated GABA-stimulated [35S]GTPγS binding to native GABAB receptors, whereas it had no effect when used alone.
• (S)-(4-(3-(tert-butoxycarbonyl)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)phenyl)methyl 2,4-dimethylbenzoate (Catalog# : 183219, Cas# : 1253955-19-9)(S)-(4-(3-(tert-butoxycarbonyl)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)phenyl)methyl 2,4-dimethylbenzoate is a drug intermediate.
• (S)-3-(tert-butoxycarbonyl)-2-(4-((2,4-dimethylbenzoyloxy)methyl)phenyl)propanoic acid (Catalog# : 183218, Cas# : 2097334-20-6)(S)-3-(tert-butoxycarbonyl)-2-(4-((2,4-dimethylbenzoyloxy)methyl)phenyl)propanoic acid is a drug intermediate.
• (S)-Butyl 2-hydroxybutanoate (Catalog# : 1712291, Cas# : 132513-51-0)butyl (2S)-2-hydroxybutanoate is building blocks.
• SCR7 pyrazine (Catalog# : 1712261, Cas# : 14892-97-8)SCR7 pyrazine is a small molecule inhibitor of DNA ligase IV that prevents nonhomologous end-joining by interfering with ligase binding and activating apoptosis.
• S38093 (Catalog# : 17101615, Cas# : 862896-30-8)S 38093 is a brain-penetrant antagonist of H3 receptor, with Ki of 8.8, 1.44 and 1.2 µM for rat, mouse and human H3 receptors, respectively.
• SAR-7334 HCl (Catalog# : 17101610, Cas# : 1333207-63-8)SAR7334 is a novel, highly potent and bioavailable inhibitor of TRPC6 channels that opens new opportunities for the investigation of TRPC channel function in vivo.
• SEN-826 (Catalog# : 1710168, Cas# : 1160833-51-1)SEN-826 is a potential anticancer agent.
• SRT3025 HCl (Catalog# : 17101310, Cas# : 2070015-26-6)SRT3025 is an orally available small molecule activator of the SIRT1 enzyme.
• Senexin A (Catalog# : 1710136, Cas# : 1366002-50-7)Senexin A is a potent and selective CDK8 inhibitor (IC50 = 280 nM). Senexin A binds to cdk19 in an ATP-competitive manner.
• S63845 (Catalog# : 171071, Cas# : 1799633-27-4)S63845 is a small molecule that specifically binds with high affinity to the BH3-binding groove of MCL1. S63845 potently kills MCL1-dependent cancer cells, including multiple mye
• Salermide (Catalog# : 1791511, Cas# : 1105698-15-4)Salermide is a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Salermide was well tolerated by mice at concentrations up to 100 muM.
• SD-06 (Catalog# : 1791320, Cas# : 271576-80-8)SD-06 is a MAPK p38 alpha inhibitor for the treatment of arthritis.
• Sulfatinib (Catalog# : 179135, Cas# : 1308672-74-3)Sulfatinib is an orally bioavailable, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, and the fibroblast growth factor receptor type
• S107 HCl (Catalog# : 1791111, Cas# : 927871-76-9)S107 is a Type 1 ryanodine receptor (RyR1) stabilizer; binds RyR1 and enhances the binding affinity of calstabin-1. Inhibits Ca leak from the sarcoplasmic reticulum (SR).
• Sematilide hydrochloride (Catalog# : 179830, Cas# : 101526-62-9)Sematilide, also known as CK-1752, is a class III antiarrhythmic. It is a selective delayed rectifier K+ current (IKr) channel blocker.
• SNX-2112 (Catalog# : 179815, Cas# : 908112-43-6)SNX-2112, also known as PF 04928473, is an Hsp90 inhibitor which is currently undergoing multiple phase 1 clinical trials.
• SU-1498 (Catalog# : 17984, Cas# : 168835-82-3)SU 1498 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2 (VEGFR2, aka FLK1; IC50 = 700 nM).
• SF2523 (Catalog# : 17918, Cas# : 1174428-47-7)SF2523 is a highly selective and potent dual pan-PI3K/BRD4 inhibitor. SF2523 exhibits a remarkable kinase selectivity inhibiting potently only 4 out of the 232 non-PI3K kinases a
• SAR-20347 (Catalog# : 1781101, Cas# : 1450881-55-6)SAR-20347 is a potent dual inhibitor of JAK1 and tyrosine kinase 2 (TYK2). 
• SB756050 (Catalog# : 20178811, Cas# : 447410-57-3)SB-756050 is a G protein-coupled bile acid receptor 1 (GPBAR1) agonist potentially for the treatment of type 2 diabetes. 
• SAR-405 (Catalog# : 2017882, Cas# : 1523406-39-4)<span style="color:#34495E;font-family:" font-size:14px;background-color:#ffffff;">SAR-405 is a potent and selective PIK3C3/Vps34 inhibitor that prevents aut
• Seco Rapamycin (sodium salt) (Catalog# : 20177313, Cas# : 148554-65-8)Seco-rapamycin is the first in vivo open-ring metabolite of rapamycin that does not affect mTOR, inhibit the ChT-L (D) (IC50>20 M)and PGPH (E) (IC50=6.45 0.78 M) peptidases, and